Jackson Creek Investment Advisors LLC Krystal Biotech, Inc. Transaction History
Jackson Creek Investment Advisors LLC
- $332 Million
- Q4 2024
A detailed history of Jackson Creek Investment Advisors LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 8,052 shares of KRYS stock, worth $1.51 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
8,052
Previous 8,296
2.94%
Holding current value
$1.51 Million
Previous $1.51 Million
16.49%
% of portfolio
0.38%
Previous 0.45%
Shares
4 transactions
Others Institutions Holding KRYS
# of Institutions
300Shares Held
24.3MCall Options Held
388KPut Options Held
233K-
Black Rock Inc. New York, NY3.95MShares$739 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.88MShares$539 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.63MShares$492 Million6.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$239 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA879KShares$165 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.8B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...